Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
“We are encouraged by these interim results, which reinforce the potential of our hormone-free contraceptive candidate to provide women with a meaningful alternative to existing hormonal and non-hormonal methods.”
Family Medicine/General Practice July 30th 2025
British Medical Journal (The BMJ)
Among 8,391 women requiring meningioma surgery, prolonged desogestrel use showed location-specific risk patterns consistent with hormone-induced tumors, primarily affecting skull base regions.
Endocrinology, Diabetes, Metabolism July 1st 2025
Updated recommendations emphasize same-day contraceptive provision with minimal examination requirements, focusing on adolescent-centered counseling that addresses individual reproductive health goals across pediatric and gynecologic practice settings.
Family Medicine/General Practice July 1st 2025
This innovative intrauterine device may allow for improvements in discontinuation rates due to pain and bleeding and in expulsion rates.
Obstetrics & Gynecology March 12th 2025
Journal of the National Cancer Institute (JNCI)
A comprehensive analysis of 176,601 cancer cases demonstrates that long-acting reversible contraceptives offer a cancer risk profile comparable to oral contraceptives, with data showing a 20-30% reduction in gynecologic cancer risk and a modest increase in breast cancer risk that returns to baseline after cessation.
Obstetrics & Gynecology February 20th 2025
The court held that damages can extend to the long-term care of the child with special needs.
Obstetrics & Gynecology February 11th 2025